11/6/2019 6:02:07 AM
Perrigo Q3 Net Sales Of $1.2 Bln, Increase 5.1%
11/4/2019 9:49:41 AM
Perrigo Co. (PRGO) Declares Quarterly Dividend of $ 0.21, Record Date 11/29/2019
11/4/2019 9:33:43 AM
Perrigo Declares Quarterly Dividend Of $0.21/shr; Payable December 17/record November 29
10/23/2019 4:13:11 PM
Perrigo Recalls Ranitidine Due To Possible Presence Of Impurity, N-nitrosodimethylamine
10/3/2019 8:02:27 AM
Perrigo Announces Relaunch Of AB Rated Generic Equivalent Of Transderm Scop
8/21/2019 8:46:00 AM
Perrigo Settles Hatch-Waxman Litigation Relating To Nascobal Nasal Spray Brought By Endo Pharma
8/8/2019 6:31:29 AM
Perrigo Q2 EPS $0.07; Adjusted EPS $0.86
8/7/2019 4:56:52 PM
Perrigo: Jeffrey Smith Resigns From Board
7/31/2019 9:57:01 AM
Perrigo Company Declares Quarterly Dividend Of $0.21/shr; Payable September 17/record August 30
7/31/2019 9:53:49 AM
Perrigo Co. (PRGO) Declares Quarterly Dividend of $ 0.21, Record Date 8/30/2019
7/8/2019 4:23:58 PM
Perrigo Completes Divestiture Of Animal Health Business To PetIQ For $185 Mln
7/3/2019 8:40:14 AM
Perrigo Announces FDA Final Approval And Launch Of AB-rated Generic Version Of Metrogel-Vaginal Gel